Skip Navigation
 

Psychiatry and Behavioral Sciences

Psychiatry Grand Rounds Speaker

  

     Charles Nemeroff, M.D., Ph.D.

  
SPEAKER BIO

Dr. Nemeroff was born in New York City in 1949 and educated in the New York City Public School System.  After graduating from the City College of New York in 1970, he enrolled in graduate school at Northeastern University and received a Master's degree in Biology in 1973.  He received his MD and PhD (Neurobiology) from the University of North Carolina at Chapel Hill. His residency training in psychiatry was conducted at both the University of North Carolina and at Duke University, after which he joined the faculty of Duke University.  At Duke he was Professor of Psychiatry and Pharmacology and Chief of the Division of Biological Psychiatry before relocating in 1991 to Emory University School of Medicine in Atlanta, Georgia, where he is the Reunette W. Harris Professor in the Department of Psychiatry and Behavioral Sciences.  His research has concentrated on the biological basis of the major neuropsychiatric disorders, including affective disorders, schizophrenia, and anxiety disorders.  His clinical research is focused on the use of genetic, neuroendocrine, neuroimaging and neurochemical methods to comprehensively understand the pathophysiology of depression.  In recent years he has uncovered the neurobiological mechanisms that mediate the increased risk for depression in victims of child abuse.  He has also contributed to other seminal findings such as the burgeoning area of research concerning the relationship of depression to cardiovascular disease, as well as to identifying predictors of specific antidepressant treatment responses.

Dr. Nemeroff has received numerous honors during his career, including the A.E. Bennett Award from the Society of Biological Psychiatry (1979), the Judith Silver Memorial Young Scientist Award from the National Alliance for the Mentally Ill (1989), both the Kempf Award in Psychobiology (1989) and the Samuel Hibbs Award (1990) from the American Psychiatric Association (APAP, and the Gold Medal Award and the Research Prize (1996) from the Society of Biological Psychiatry.  In 1993 he was awarded the Edward J. Sachar Award from Columbia University and the Edward A. Strecker Award from The Institute of Pennsylvania Hospital.  In 1997, he was the recipient of the Gerald Klerman Award from the National Depressive and Manic-Depressive Disorders Association and the Selo Prize from the National Alliance for Research in Schizophrenia and Depression.  In 1998 he was the recipient of the Research Award in Mood Disorders from the American College of Psychiatrists and in 1999 he received the Bowis Award from the same organization.  He was awarded the Menninger Prize in 2000 from the American College of Physicians, the Research Award from the American Foundation for Suicide Prevention in 2001, and the Burlingame Prize from the Institute of Living in 2002.  In 2006 he received the American Psychiatric Association Research Mentoring Award and Vestermark Award, and, in 2008 the Marmor Prize. Dr. Nemeroff served as the Editor-in-Chief of Neuropsychopharmacology (2001-2006).  With Alan F. Schatzberg, MD, he is co-Editor of the Textbook of Psychopharmacology, soon to be in its Fourth Edition, published by the American Psychiatric Association Press. He has served on the Mental Health Advisory Council of the National Institutes of Mental Health and the Biomedical Research Council for NASA. He is past President of the American College of Neuropsychopharmacology and the American College of Psychiatrists. He is currently a member of the Board of Directors of the American Foundation for Suicide Prevention. He is chair of the APA Committee on Research Training. In 2002 he was elected as a member of the Institute of Medicine of the National Academy of Sciences.

He has published more than 900 research reports and reviews. 

  
  
      OBJECTIVES                                                                                                                                                               
         At the completion of this session, the participant should be able to:
       

1.) To understand HPA axis alterations in depression

2.) To understand the role of early adverse experiences on the development of depression in adulthood

3.)  To understand the long-term effects of early adverse experience on the central nervous system of adults

       

« back to March calendar

 
 
 

© 2014  Medical University of South Carolina | Disclaimer